Crabb, S. J., Griffiths, G., Marwood, E., Dunkley, D., Downs, N., Martin, K., . . . Jones, R. J. (2021). Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID). J Clin Oncol.
Čikaški stil citiranjaCrabb, Simon J., et al. "Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)." J Clin Oncol 2021.
MLA način citiranjaCrabb, Simon J., et al. "Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)." J Clin Oncol 2021.